Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies

Journal of Virology

Volumn 87, Issue 18, 2013, Pages 10405-10410

  Fofana, Isabel ^a,b   Zona, Laetitia ^a,b   Thumann, Christine ^a,b   Heydmann, Laura ^a,b   Durand, Sarah C ^a,b   Lupberger, Joachim ^a,b,c   Blum, Hubert E ^c   Pessaux, Patrick ^a,b,d   Gondeau, Claire ^a   Reynolds, Gary M ^e   McKeating, Jane A ^e   Grunert, Fritz ^f   Thompson, John ^f   Zeisel, Mirjam B ^a,b   Baumert, Thomas F ^b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f Aldevron GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; CLAUDIN; CLAUDIN 6; CLAUDIN 9; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CROSS REACTION; DOSE RESPONSE; EMBRYO; GENOTYPE; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA VIRUS INFECTION; VIRUS ENTRY; VIRUS INHIBITION;

ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CLAUDINS; HEPACIVIRUS; HEPATOCYTES; HUMANS; VIRUS INTERNALIZATION;

EID: 84883261383     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01691-13     Document Type: Article

References (21)

1. Meredith LW, Wilson GK, Fletcher NF, McKeating JA. 2012. Hepatitis C virus entry: beyond receptors. Rev. Med. Virol. 22:182-193.
2. Zeisel MB, Lupberger J, Fofana I, Baumert TF. 2013. Host-targeting agents for prevention and treatment of chronic hepatitis C: perspectives and challenges. J. Hepatol. 58:375-384.
3. Martin DN, Uprichard SL. 2013. Identification of transferrin receptor 1 as a hepatitisCvirus entry factor. Proc. Natl. Acad. Sci. U. S. A. 110:10777-10782.
4. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805.
5. Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, Mee C, Soulier E, Royer C, Lambotin M, Grunert F, Dao Thi VL, Dreux M, Cosset FL, McKeating JA, Schuster C, Baumert TF. 2010. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology 51:1144-1157.
6. Fofana I, Krieger SE, Grunert F, Glauben S, Xiao F, Fafi-Kremer S, Soulier E, Royer C, Thumann C, Mee CJ, McKeating JA, Dragic T, Schuster C, Thompson J, Baumert TF. 2010. Monoclonal anti-claudin 1 antibodies for prevention of hepatitis C virus infection. Gastroenterology 139:953-964, 964.e951-954.
7. Harris HJ, Davis C, Mullins JG, Hu K, Goodall M, Farquhar MJ, Mee CJ, McCaffrey K, Young S, Drummer H, Balfe P, McKeating JA. 2010. Claudin association with CD81 defines hepatitis C virus entry. J. Biol. Chem. 285:21092-21102.
8. Harris HJ, Farquhar MJ, Mee CJ, Davis C, Reynolds GM, Jennings A, Hu K, Yuan F, Deng H, Hubscher SG, Han JH, Balfe P, McKeating JA. 2008. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J. Virol. 82:5007-5020.
9. Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris HJ, Barnes A, Florentin J, Tawar RG, Xiao F, Turek M, Durand SC, Duong FH, Heim MH, Cosset FL, Hirsch I, Samuel D, Brino L, Zeisel MB, Le Naour F, McKeating JA, Baumert TF. 2013. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host Microbe 13:302-313.
10. Zheng A, Yuan F, Li Y, Zhu F, Hou P, Li J, Song X, Ding M, Deng H. 2007. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. J. Virol. 81:12465-12471.
11. Meertens L, Bertaux C, Cukierman L, Cormier E, Lavillette D, Cosset FL, Dragic T. 2008. The tight junction proteins claudin-1,-6, and-9 are entry cofactors for hepatitis C virus. J. Virol. 82:3555-3560.
12. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
13. Shaw G, Morse S, Ararat M, Graham FL. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16:869-871.
14. Zahid MN, Turek M, Xiao F, Dao Thi VL, Guerin M, Fofana I, Bachellier P, Thompson J, Delang L, Neyts J, Bankwitz D, Pietschmann T, Dreux M, Cosset FL, Grunert F, Baumert TF, Zeisel MB. 2013. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination. Hepatology 57:492-504.
15. Da Costa D, Turek M, Felmlee DJ, Girardi E, Pfeffer S, Long G, Bartenschlager R, Zeisel MB, Baumert TF. 2012. Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells. J. Virol. 86:11919-11925.
16. Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, Leroux-Roels G, Patel AH, Cosset FL, Pessaux P, Doffoël M, Wolf P, Stoll-Keller F, Baumert TF. 2010. Enhanced viral entry and escape from antibody-mediated neutralization are key determinants for hepatitis C virus re-infection in liver transplantation. J. Exp. Med. 207:2019-2031.
17. Haid S, Grethe C, Dill MT, Heim M, Kaderali L, Pietschmann T. 14 June 2013, posting date. Isolate-dependent use of Claudins for cell entry by hepatitis C virus. Hepatology. doi:10.1002/hep.26567.
18. Fofana I, Xiao F, Thumann C, Turek M, Zona L, Tawar RG, Grunert F, Thompson J, Zeisel MB, Baumert TF. 2013. A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits hepatitis C virus cell-cell transmission. PLoS One 8:e64221. doi:10.1371 /journal.pone.0064221.
19. Bartosch B, Dubuisson J, Cosset FL. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197:633-642.
20. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R. 2006. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80:5308-5320.
21. Reynolds GM, Harris HJ, Jennings A, Hu K, Grove J, Lalor PF, Adams DH, Balfe P, Hubscher SG, McKeating JA. 2008. Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 47: 418-427.